Home › Liver Cancer (Hepatocellular Carcinoma) › NCT03959800

Molecular Basis of Pediatric Liver Cancer

Genetic and Molecular Basis of Pediatric Liver Cancer

Who can join

Ages 0 to 99 · All sexes

Inclusion Criteria:

* Prior or current treatment for a childhood liver tumor, malignant or benign, at age \<21 years.
* Biological parents and siblings of eligible children.

Exclusion Criteria:

* No prior or current treatment for a childhood liver tumor.
* Non-biological parents, legal guardians, or non-biological siblings of eligible children.

About the study

The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.

Sponsor: University of Pittsburgh · Participants: 1,600 · Started: Jun 22, 2015

Contact the study team

• Morgan Paul, BSN · Phone: (412) 692-8472
• Daniel Pieratt, MPA · Phone: (412) 692-6692

Official record on ClinicalTrials.gov — NCT03959800

Locations in the U.S.

Conditions

• Liver Cancer (Hepatocellular Carcinoma)
• Hepatoblastoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.